These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31691380)

  • 1. Low serum miR-223 expression predicts poor outcome in patients with acute myeloid leukemia.
    Yu G; Yin Z; He H; Zheng Z; Chai Y; Xuan L; Lin R; Wang Q; Li J; Xu D
    J Clin Lab Anal; 2020 Mar; 34(3):e23096. PubMed ID: 31691380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of serum MicroRNA-203 in patients with acute myeloid leukemia.
    Guo Y
    Bioengineered; 2019 Dec; 10(1):345-352. PubMed ID: 31411110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High serum extracellular vesicle miR-10b expression predicts poor prognosis in patients with acute myeloid leukemia.
    Fang Z; Wang X; Wu J; Xiao R; Liu J
    Cancer Biomark; 2020; 27(1):1-9. PubMed ID: 31594209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulated miR-217 expression predicts a poor outcome in acute myeloid leukemia.
    Yan J; Wu G; Chen J; Xiong L; Chen G; Li P
    Cancer Biomark; 2018; 22(1):73-78. PubMed ID: 29439315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia.
    Lin X; Wang Z; Wang Y; Feng W
    Int J Clin Exp Pathol; 2015; 8(11):14658-66. PubMed ID: 26823789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low miR-192 expression predicts poor prognosis in pediatric acute myeloid leukemia.
    Tian C; Zhang L; Li X; Zhang Y; Li J; Chen L
    Cancer Biomark; 2018; 22(2):209-215. PubMed ID: 29689705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum miR-22 is a novel prognostic marker for acute myeloid leukemia.
    Qu H; Zheng G; Cheng S; Xie W; Liu X; Tao Y; Xie B
    J Clin Lab Anal; 2020 Sep; 34(9):e23370. PubMed ID: 32533562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of serum miR-34a as a potential biomarker in acute myeloid leukemia.
    Huang Y; Zou Y; Lin L; Ma X; Chen H
    Cancer Biomark; 2018; 22(4):799-805. PubMed ID: 29945348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum miR-133 as a novel biomarker for predicting treatment response and survival in acute myeloid leukemia.
    Zheng ZZ; Ma YP; Wu RH; Rong G; Li C; Li GX; Ren FG; Xu LJ
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):777-783. PubMed ID: 32016982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of dysregulation of miR-381 in pediatric acute myeloid leukemia.
    Zhang P; Sun D; Sun X; Li H
    Eur J Med Res; 2020 Sep; 25(1):42. PubMed ID: 32938467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia.
    Fayyad-Kazan H; Bitar N; Najar M; Lewalle P; Fayyad-Kazan M; Badran R; Hamade E; Daher A; Hussein N; ElDirani R; Berri F; Vanhamme L; Burny A; Martiat P; Rouas R; Badran B
    J Transl Med; 2013 Feb; 11():31. PubMed ID: 23391324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic relevance of serum miR-195 in pediatric acute myeloid leukemia.
    Hong Z; Zhang R; Qi H
    Cancer Biomark; 2018 Feb; 21(2):269-275. PubMed ID: 29226854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High serum microRNA-335 level predicts aggressive tumor progression and unfavorable prognosis in pediatric acute myeloid leukemia.
    Lin X; Wang Z; Zhang R; Feng W
    Clin Transl Oncol; 2015 May; 17(5):358-64. PubMed ID: 25301405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-106b-5p and Rab10: Potential Markers of Acute Myeloid Leukemia.
    Xu L; Wang A; Guan H
    Cancer Biother Radiopharm; 2024 Sep; 39(7):492-501. PubMed ID: 38949985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of miR-210 is Associated with Poor Prognosis of Acute Myeloid Leukemia.
    Tang X; Chen L; Yan X; Li Y; Xiong Y; Zhou X
    Med Sci Monit; 2015 Nov; 21():3427-33. PubMed ID: 26549593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
    Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
    Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum level of miR-10-5p as a prognostic biomarker for acute myeloid leukemia.
    Zhi Y; Xie X; Wang R; Wang B; Gu W; Ling Y; Dong W; Zhi F; Liu Y
    Int J Hematol; 2015 Sep; 102(3):296-303. PubMed ID: 26134365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of circulating microRNAs as potential biomarkers for detecting acute myeloid leukemia.
    Zhi F; Cao X; Xie X; Wang B; Dong W; Gu W; Ling Y; Wang R; Yang Y; Liu Y
    PLoS One; 2013; 8(2):e56718. PubMed ID: 23437222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and prognostic significance of serum miR-203 in patients with acute myeloid leukemia.
    Zheng Z; Rong G; Li G; Ren F; Ma Y
    Int J Clin Exp Pathol; 2019; 12(5):1548-1556. PubMed ID: 31933972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia.
    Liu L; Chen R; Zhang Y; Fan W; Xiao F; Yan X
    Diagn Pathol; 2015 Jul; 10():109. PubMed ID: 26185105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.